STRO
Sutro Biopharma
15.30$
+4.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 2.6% | 1.5% | 13.5% | 7.0% | 21.1% | -11.7% | – | 3.0% | 19.6% | 13.9% | 8.8% | – | – | |
| 100.0% | 100.0% | 86.5% | 93.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 91.2% | 100.0% | 97.2% | |
| 269.8% | 47.3% | 437.3% | 241.3% | 729.0% | 479.7% | 296.6% | 60.1% | 411.2% | 314.6% | 251.7% | 322.1% | 316.7% | |
| 90.2% | 14.8% | 97.8% | 48.1% | 168.2% | 61.0% | 76.3% | 16.2% | 90.2% | 74.4% | 52.2% | 79.6% | 71.8% | |
| 360.1% | 62.1% | 521.5% | 282.4% | 897.2% | 540.7% | 493.8% | 105.2% | 599.9% | 389.0% | 295.1% | 403.8% | 407.1% | |
| -260.1% | 37.9% | -435.0% | -189.4% | -797.2% | -440.7% | -393.8% | -5.2% | -499.9% | -289.0% | -203.9% | -303.8% | -309.9% | |
| 51.3% | 7.7% | 72.2% | 35.2% | 92.8% | 58.7% | 61.2% | 15.1% | 107.4% | 88.7% | 65.2% | 100.2% | 87.7% | |
| -280.3% | 41.2% | -447.5% | -186.8% | -572.6% | -473.3% | -436.6% | -18.1% | -586.6% | -402.2% | -265.1% | -391.6% | -395.5% | |
| 10.9% | 13.9% | 13.2% | 0.0% | – | 15.9% | – | 0.0% | – | -0.7% | -0.1% | 0.0% | – | |
| -291.2% | 27.3% | -447.5% | -186.8% | -572.6% | -489.2% | -436.6% | -18.0% | -586.6% | -401.5% | -265.0% | -391.6% | -395.2% | |
| -218.8% | 50.4% | -378.8% | -151.5% | -458.7% | -402.0% | -261.9% | 1.7% | -459.6% | -299.6% | -191.1% | -278.6% | -294.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.